Condition: Solid Tumors · Advanced Cancer · Renal Cancer · Sponsor: Apollomics Inc.
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring wild-type MET with overexpression of HGF and MET * efficacy of APL-101 as an add-on therapy to EGFR inhibitor for the treatment of NSCLC harboring EGFR activating mutations and developed acquired resistance with MET amplification and disease progression after documented CR or PR with 1st line EGFR inhibitors (EGFR-I)
This description comes directly from the study's public registry record.
Emma (Xiaoning) Cai · +1 6502094055 · clinops@apollomicsinc.com
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute | Los Angeles, California, United States | Recruiting |
| Moffitt | Tampa, Florida, United States | Active Not Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Active Not Recruiting |
| University of North Carolina | Chapel Hill, North Carolina, United States | Recruiting |
| Penn State Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| University of Wisconsin | Madison, Wisconsin, United States | Recruiting |
| St Vincents Hospital Melbourne | Melbourne, Australia | Recruiting |
| Cross Cancer Institute | Edmonton, Canada | Recruiting |
| McGill University Health Center - Research Institute | Montreal, Canada | Recruiting |
| Princess Margaret Hospital | Toronto, Canada | Recruiting |
| Cancer Care Manitoba | Winnipeg, Canada | Recruiting |
| CHRU de Brest - Hôpital Morvan | Brest, France | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03175224